IM Cannabis Corp. (IMCC)
NASDAQ: IMCC · Real-Time Price · USD
2.040
-0.130 (-5.99%)
At close: Oct 2, 2026, 4:00 PM EDT
2.010
-0.030 (-1.47%)
After-hours: Oct 2, 2026, 7:59 PM EDT
Company Description
IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany.
It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands.
The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.
IM Cannabis Corp.
| Country | Canada |
| Founded | 1980 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 44 |
| CEO | Oren Shuster |
Contact Details
Address: 3606 – 833 Seymour Street Vancouver, BC V6B 0G4 Canada | |
| Website | imcannabis.com |
Stock Details
| Ticker Symbol | IMCC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| CIK Code | 1792030 |
| CUSIP Number | 44969Q505 |
| ISIN Number | CA44969Q5059 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Eyal Fisher | Chief Executive Officer of the IMC Holdings |
| Richard Balla | Chief Executive Officer of Adjupharm |
| Oren Shuster | Chief Executive Officer and Executive Director |
| Asi Levi | Chief Financial Officer |
| Anna Taranko | Director Investor and Public Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 2, 2026 | 6-K | Report of foreign issuer |
| Sep 30, 2026 | SCHEDULE 13G | Filing |
| Sep 30, 2026 | SCHEDULE 13G | Filing |
| Sep 30, 2026 | SCHEDULE 13G | Filing |
| Sep 28, 2026 | 6-K | Report of foreign issuer |
| Sep 25, 2026 | 6-K | Report of foreign issuer |
| Sep 24, 2026 | 424B5 | Filing |
| Sep 24, 2026 | 6-K | Report of foreign issuer |
| Sep 23, 2026 | 6-K | Report of foreign issuer |
| Sep 23, 2026 | 6-K | Report of foreign issuer |